Selection ofCandida Glabratain Pediatric Bone Marrow Transplant Recipients Receiving Fluconazole
- 1 January 1994
- journal article
- case report
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 11 (2) , 207-210
- https://doi.org/10.3109/08880019409141658
Abstract
We observed an alarmingly high rate (5/16 patients; 31.3%) of orointestinal colonization with Candida glabrata— often in high numbers—in pediatric bone marrow transplant recipients receiving fluconazole as antfungal prophylaxis. This selection is probably due to the intrimically low swceptibility of C. glabrata to fluconuzole.Keywords
This publication has 15 references indexed in Scilit:
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992
- Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with FluconazoleNew England Journal of Medicine, 1991
- Emergence ofCandida krusei infections after therapy of oropharyngeal candidiasis with fluconazoleEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- FluconazoleDrugs, 1990
- Carriage of Candida species and C albicans biotypes in patients undergoing chemotherapy or bone marrow transplantation for haematological disease.Journal of Clinical Pathology, 1989
- Fungemia in a Cancer Hospital: Changing Frequency, Earlier Onset, and Results of TherapyClinical Infectious Diseases, 1985
- Latex agglutination test for detection of Candida antigen in patients with disseminated diseaseEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- Torulopsis glabrata Fungemia—A Clinical Pathological StudyMedicine, 1979